Original Research
Accepted on 28 May 2025
The meaning of manageable neuropathic pain after SCI
in Non-Pharmacological Treatment of Pain
Frontiers in Pain Research
doi 10.3389/fpain.2025.1540395
596,549 articles related to "Completely Randomized Design"
Articles
Original Research
Accepted on 28 May 2025
Effects of Different Incremental Treadmill Exercise Protocols on the Autonomic Nervous System in Healthy College Students: A Comparative Study Based on Heart Rate Variability Analysis
in Exercise Physiology
Frontiers in Physiology
doi 10.3389/fphys.2025.1579929
Editorial
Accepted on 28 May 2025
Editorial: Current Treatment Strategies and Integrative Medicine for Management of Pain in Sickle Cell Disease
in Pharmacological Treatment of Pain
Frontiers in Pain Research
doi 10.3389/fpain.2025.1621147
Original Research
Accepted on 28 May 2025
Differential Metabolic Pathways Underlie THC-and CBD-Mediated Inhibition of B-Cell Activation in Both Young and Aged Mice
in Immunological Tolerance and Regulation
Frontiers in Immunology
doi 10.3389/fimmu.2025.1605474
Mini Review
Accepted on 28 May 2025
Stabilization of Emulsified Edible Coating Using Cellulose Nanomaterials for Fruit Preservation
in Agro-Food Safety
Frontiers in Sustainable Food Systems
doi 10.3389/fsufs.2025.1618714
Brief Research Report
Accepted on 28 May 2025
Impact of Pretransplant Vitamin D Deficiency on Immune Recovery and Clinical Outcomes in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
in Nutritional Immunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1588919
Systematic Review
Accepted on 28 May 2025
Association between pro-inflammatory diet and ulcerative colitis: a systematic review and meta-analysis
in Nutrition and Sustainable Diets
Frontiers in Nutrition
doi 10.3389/fnut.2025.1586691
Review
Accepted on 28 May 2025
Recent Advances in Dermal Fibroblast Senescence and Skin Aging: Unraveling Mechanisms and Pioneering Therapeutic Strategies
in Integrative and Regenerative Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1592596
Original Research
Accepted on 28 May 2025
The F1F3 recombinant chimera induced higher vaccine efficacy than its independent F1 and F3 components against Leishmania (L.) infantum chagasi mice infection.
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2025.1598755
Original Research
Accepted on 28 May 2025
Comparative study of flow rate-and material-dependent human plasma protein adsorption on oxygenator membranes and heat exchanger materials
in Thrombosis and Haemostasis
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2025.1578538
Original Research
Accepted on 28 May 2025
Residual beta-cell function in children with type 1 diabetes after a partial remission phase -a possible relation between C-peptide and betatrophin
in Clinical Diabetes
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1602777
Original Research
Accepted on 28 May 2025
Exploring Barriers and Drivers to a modified WHO Safe Childbirth Checklist implementation in three West African Countries: a qualitative study using the updated Consolidated Framework for implementation Research (CFIR)
in Implementation Science
Frontiers in Health Services
doi 10.3389/frhs.2025.1593083
Review
Accepted on 28 May 2025
Cotton production in the Yellow River Basin of China: Reforming cropping systems for ecological, economic stability and sustainable production
in Agricultural and Food Economics
Frontiers in Sustainable Food Systems
doi 10.3389/fsufs.2025.1615566
Original Research
Accepted on 28 May 2025
Tricin selectively combats KRAS-mutant non-small cell lung cancer by inhibiting the PDGF-BB-induced SRC/MAPK/AP-1/PD-L1 signaling pathway and potentiating the antitumor effect of an anti-PD-1 antibody
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1594213
Original Research
Accepted on 28 May 2025
An integrated approach based on FDA Adverse Event Reporting System (FAERS), network pharmacology, molecular docking, and molecular dynamics simulation analysis to study the cardiac adverse reactions and mechanism of action of osimertinib
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1619517
Review
Accepted on 28 May 2025
Multiple myeloma inhibitory effects of natural compounds: enhancement through nanoparticle carriers
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1589090